This is a working overview of thymalfasin, written for readers who want more than a one-paragraph summary but less than a textbook.
This page was last updated on 2025-10-15 and is reviewed periodically as new material appears.
The compound has been investigated as an adjunct in chronic viral hepatitis and as a vaccine adjuvant, with results that vary by study design and population. Regulators in some countries have approved a synthetic form for specific indications, while other agencies have not. Whether the peptide produces consistent clinical benefit across diverse patient groups is still an open question, and many trials have been small. Its status is therefore best described as investigational in many contexts and established only narrowly.
The name itself causes confusion, because several unrelated thymic peptides share the thymosin label. Thymosin beta-4, for example, is a different molecule with different functions. Naming conventions in the literature also mix descriptive research terms with assigned nonproprietary names, so a reader should confirm which entity a given paper addresses. Clarifying that point is usually the first step in interpreting any claim about this peptide.
Thymosin alpha 1 is a short peptide of 28 amino acid residues that derives from the amino terminal region of a larger precursor protein known as prothymosin alpha. The peptide carries an acetyl group on its first residue and contains no disulfide bonds or carbohydrate chains. Its sequence is highly conserved across mammalian species, which is one reason laboratories treat it as a molecule with a defined and reproducible structure rather than a variable tissue extract. The name follows an early naming convention for thymus-derived fractions and does not imply that the peptide acts as a hormone in the classical endocrine sense.
Biologically, the peptide is studied mainly in the context of immune cell development and regulation. It is produced in the thymus and in several other tissues, and it appears to influence the maturation and activity of T cells and other immune populations. Laboratory work describes effects on cytokine production, on the balance between T cell subsets, and on the function of dendritic cells. Much of this evidence comes from cell culture and animal models, so the extent to which the same pathways operate in humans remains an open question.
| Property | Value | Notes |
|---|---|---|
| Residue count | 28 amino acids | Acetyl group on the first residue |
| Approximate molecular mass | 3108 daltons | Calculated from the consensus sequence |
| Origin | Cleavage product of prothymosin alpha | Not encoded as a separate gene product |
| Primary research focus | Immune modulation | Studied in viral hepatitis and as a vaccine adjuvant |
| Common synonyms | Thymalfasin, Tα1, thymosin alpha 1 | Thymalfasin is the assigned nonproprietary name |
Recommended storage for the dry powder is a freezer near minus twenty degrees Celsius, kept desiccated and away from light. Once dissolved, the peptide is less stable and is usually held at two to eight degrees Celsius for short intervals or frozen for longer storage. Stability studies focus on the acetylated terminus and the disulfide linkage because those features define the intact molecule. Common degradation routes include cysteine oxidation, deamidation of asparagine or glutamine side chains, and slow formation of higher-molecular-weight species.
Identity and purity are usually checked by reverse-phase high-performance liquid chromatography, which separates the intact chain from truncated products, together with mass spectrometry for confirmation of the expected mass. Peptide mapping after enzymatic digestion and amino acid analysis add sequence-level evidence. Release testing also covers water content, residual solvents, and counter-ions, all of which influence measured mass and stability. Related-peptide limits are commonly expressed as a percentage of total peak area, with individual unspecified impurities held below a lower threshold.
Clinical research has examined the peptide in chronic hepatitis B and C, as a vaccine adjuvant, and in sepsis and oncology settings. Results across trials have been mixed, and several studies were small or conducted under differing protocols. Regulatory status varies by country, and the compound is not approved in every jurisdiction where it is studied. Evidence for any single indication should be read with attention to sample size and endpoint choice.
Thymosin alpha-1 is a 28-residue peptide first isolated from thymus tissue in the 1970s. It corresponds to the N-terminal portion of thymosin beta-4, from which it is cleaved in vivo. The peptide carries an acetyl group at its N-terminus, a modification that affects its charge and stability. Synthetic material produced by solid-phase peptide synthesis is chemically identical to the natural fragment and is the form used in research and clinical studies.
Laboratory work indicates that the peptide acts on cells of both the innate and adaptive immune systems. Reported effects include signalling through Toll-like receptors on dendritic cells, enhanced T-cell maturation, and increased natural killer cell activity. These actions are described largely from cell-culture and animal experiments, and the precise receptor-level events remain incompletely defined. Studies in humans have generally measured immune markers rather than a single defined molecular target. The resulting picture remains partly descriptive.
1993/3026) Value Added Tax (General) (Amendment) (No.7) Regulations 1993 (S.I. 1993/3027) Value Added Tax (Cash Accounting) (Amendment) (No. 2) Regulations 1993 (S.I. 1993/3028) Trade Marks and Service Marks (Fees) (Amendment) Rules 1993 (S.I. 1993/3029) Local Government Superannuation (Educational Institutions) Regulations 1993 (S.I. 1993/3030) Transfrontier Shipment of Radioactive Waste Regulations 1993 (S.I. 1993/3031) Gipsy Encampments (Metropolitan District of Salford) Order 1993 (S.I. 1993/3032) A564 Trunk Road Stoke—Derby Route (Doveridge Bypass and Slip Roads) Order 1993 (S.I. 1993/3033) A564 Trunk Road Stoke—Derby Route (Doveridge Bypass) (Detrunking) Order 1993 (S.I. 1993/3034) Local Government Act 1988 (Defined Activities) (Exemption) (Cambridge City Council) Order 1993 (S.I. 1993/3035) Sheep Annual Premium and Suckler Cow Premium Quotas (Amendment) Regulations 1993 (S.I. 1993/3036) Census of Production Order 1993 (S.I. 1993/3037) Licensing of Air Carriers (Second Amendment and Other Provisions) Regulations 1993 (S.I. 1993/3039) Access for Community Air Carriers to Intra-Community Air Routes (Amendment and Other Provisions) Regulations 1993 (S.I. 1993/3040) Air Fares (Second Amendment) Regulations 1993 (S.I. 1993/3041) Airports Slot Allocation (Amendment) Regulations 1993 (S.I. 1993/3042) Local Government Superannuation (Membership) Regulations 1993 (S.I. 1993/3043) Local Government Superannuation (Scotland) Amendment (No.3) Regulations 1993 (S.I. 1993/3044) Land Registration (Leasehold Reform) Rules 1993 (S.I.
== Religious function == The ability of pigmented strains of Serratia marcescens to grow on bread has led to a possible explanation of Medieval transubstantiation miracles, in which Eucharistic bread is converted into the Body of Christ. Such miracles led to Pope Urban IV instituting the Feast of Corpus Christi in 1264. This followed celebration of a Mass at Bolsena in 1263, led by a Bohemian priest who had doubts concerning transubstantiation. During the Mass, the eucharist appeared to bleed and each time the priest wiped away the blood, more would appear. This event is celebrated in a fresco in the Pontifical Palace in the Vatican City, painted by Raphael: The Mass at Bolsena.
== Deaths == January 6 – Alex Felipe, 32, futsal player (Sporting CP, Norilsk Nickel, national team) January 10 – Isabel Veloso, 19, social media influencer January 24 – Constantino de Oliveira Júnior, 57, founder and CEO (2004–2012) of Gol Linhas Aéreas February 4 – Ricardo Schnetzer, 72, voice actor February 13 – José Álvaro Moisés, 81, political scientist. April 17 – Oscar Schmidt, 68, Hall of Fame basketball player (JuveCaserta, Corinthians, national team). April 18 – Oscar Andrade, 68, deputy (1996–2003). April 19 – Gerardo Renault, 96, Minas Gerais MLA (1968–1978), deputy (1978–1986). April 27 – Luciana Novaes, 42, social worker, politician, and Rio de Janeiro city councilwoman. May 4 – Hermano da Silva Ramos, 100, French-Brazilian racing driver (Formula One). May 2 – Raimundo Rodrigues Pereira, 85, journalist. May 5 – Guto Graça Mello, 78, composer and music producer. May 23 – Gabriel Ganley, 22, bodybuilder and social media influencer. June 9 – Orlando Senna, 86, film director (Iracema: Uma Transa Amazônica). June 11 – Brito, 86, football player. June 14 – Oliver Tree, 32, American singer-songwriter. Lucas Frota, 27, record producer, musician, and DJ. June 19 – Brasão, 44, footballer (Athletico Paranaense, Santa Cruz, Salgaocar). July 3 – Lydia Möcklinghoff, 45, German ecologist and zoologist. July 7 – Benedito Ruy Barbosa, 95, telenovela writer (Pantanal, O Rei do Gado, Terra Nostra). July 16 – Renato Machado, 83, newscaster and journalist (TV Globo). July 26 – Octavio Gallotti, 95, minister (1984–2000) and president (1991, 1993–1995) of the Supreme Federal Court.
Sources: en.wikipedia.org
The beta particles from small amounts of tritium cause chemicals called phosphors to glow. This radioluminescence is used in self-powered lighting devices called betalights, which are used for night illumination of firearm sights, watches, exit signs, map lights, navigational compasses (such as current-use M-1950 U.S. military compasses), knives and a variety of other devices. As of 2000, commercial demand for tritium is 400 grams (0.88 lb) per year and the cost is $30,000 per gram ($850,000/oz) or more.
These employ the same radioligands and have the same uses as SPECT scanning, but are able to provide even finer 3-D localization of high-uptake tissues, in cases where finer resolution is needed. An example is the sestamibi parathyroid scan which is performed using the 99mTc radioligand sestamibi, and can be done in either SPECT or SPECT/CT machines.
==== New Zealand ==== In 2017, the New Zealand government made changes to the regulations so that restrictions would be removed, which meant a doctor was able to prescribe cannabidiol to patients. The passing of the Misuse of Drugs (Medicinal Cannabis) Amendment Act in December 2018 means cannabidiol is no longer a controlled drug in New Zealand, but is a prescription medicine under the Medicines Act, with the restriction that "the tetrahydrocannabinols (THCs) and specified substances within the product must not exceed 2 percent of the total CBD, tetrahydrocannabinol (THC) and other specified substances."
== Bilingual status == Under the University College Galway Act, 1929 (which came into effect on 17 December 1929), the university was given special statutory responsibility with respect of the use of the Irish language as a working language of the university. The Act of 1929 provided that when recruiting a person to work for the university, a person competent in the Irish language must be appointed to the position unless no such person with the necessary competence to carry out the role could be found among the candidates for the position. As a result, every president appointed to the university thereafter was fluent in Irish. The university's governing authority complained that this requirement limited the pool of potential candidates for the office of president (in particular, candidates from overseas). As a result, the Act was amended in 2006 to replace the requirement for fluency in the Irish language amongst staff and management with a commitment to provide for education through the Irish language. In 2016, the university amended its recruitment criteria to allow for the possibility of a non-Irish-speaking president. In August 2025, a non-Irish-speaking president was appointed to the university for the first time since the appointment of Alexander Anderson in 1899.
Sources: en.wikipedia.org
It is usually classified as an immunomodulatory peptide rather than a classical hormone. It derives from the larger protein prothymosin alpha and acts mainly on immune cells. The thymosin label covers a group of distinct peptides, so the naming can be misleading.
The two share a family name but have different sequences, sizes, and functions. Thymosin beta-4 is a 43-residue peptide associated with actin binding and cell migration. Thymosin alpha-1 is a 28-residue peptide linked mainly to immune signaling.
Thymalfasin is the assigned international nonproprietary name for the synthetic 28-residue peptide. Thymosin alpha-1 is the descriptive research name for the same molecule. Which term appears depends on the context and the regulatory document.
The name reflects an early convention for naming thymus-derived fractions. The peptide is characterized and measured as a defined molecule, and it does not operate through a single classical endocrine axis.